Unique ID issued by UMIN | UMIN000001056 |
---|---|
Receipt number | R000001267 |
Scientific Title | Study in Tohoku Preventive Effect of Camostat on Progression of Chronic Pancreatitis |
Date of disclosure of the study information | 2008/03/01 |
Last modified on | 2022/11/17 17:13:07 |
Study in Tohoku Preventive Effect of Camostat on Progression of Chronic Pancreatitis
Study in Tohoku Preventive Effect of Camostat on Progression of Chronic Pancreatitis (STOPCP)
Study in Tohoku Preventive Effect of Camostat on Progression of Chronic Pancreatitis
Study in Tohoku Preventive Effect of Camostat on Progression of Chronic Pancreatitis (STOPCP)
Japan |
chronic pancreatitis
recurrent pancreatitis
alcoholic acute pancreatitis
Hepato-biliary-pancreatic medicine |
Others
NO
Medical treatment for chronic pancreatitis has been intended to ameliorate subjective symptom such as abdominal pain. Oral pancreatic enzymes has been used generally to treat the symptom of chronic pancreatitis. In Japan, oral proteinase inhibitor camostat mesilate (Foipan) has been also used to treat chronic pancreatitis. Here we examine the efficacy of Foipan in preventing the progression of chronic pancreatitis by an open, prospective, multicenter, randomised controlled trial.
Efficacy
Confirmatory
Pragmatic
Not applicable
frequency of pancreatitis attacks
quality of life
glucose tolerance
pancreatic exocrine function
pancreatic fibrosis
pancreatic inflammation
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
NO
Institution is considered as a block.
YES
Central registration
2
Treatment
Medicine |
1 tablet of Foipan to be taken three times a day (300mg/day) after meals for 21 months, following 2 tablets of Foipan three times a day (600mg/day) for 3 months.
1 gram of Berizym (granules) to be taken three times a day (3 gram /day) after meals for 24 months.
20 | years-old | <= |
Not applicable |
Male and Female
Patients who recieved hospital treatment for recurrent pancreatitis or acute exacerbation of chronic pancreatitis.
Outpatients with chronic pancreatitis.
Patients with alcoholic acute pancreatitis.
1) Patients under 20 years old.
2) Patients with contraindications to Foipan or Berizym.
3) Patients scheduled for surgery, endoscopic treatment, or extracorporeal shock wave lithotripsy(ESWL) as treatment for pancreatitis.
4) Patients whom the attending doctor consider inappropiate to participate in this clinical study for some reason.
200
1st name | Tooru |
Middle name | |
Last name | Shimosegawa |
Tohoku University Graduate School of Medicine
Division of Gastroenterology
9808574
1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan
022-717-7171
tshimosegawa@int3.med.tohoku.ac.jp
1st name | Atsushi |
Middle name | |
Last name | Masamune |
Tohoku University Graduate School of Medicine
Division of Gastroenterology
980-8574
1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan
022-717-7171
amasamune@med.tohoku.ac.jp
Tohoku University Graduate School of Medicine
Division of Gastroenterology
Ministry of Education, Culture, Sports, Science and Technology
Japanese Governmental office
Japan
Ethics Committee Tohoku University Graduate School of Medicine
1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan
022-717-7000
med-kenkyo@bureau.tohoku.ac.jp
NO
2008 | Year | 03 | Month | 01 | Day |
na
Unpublished
na
100
unpublished
2022 | Year | 11 | Month | 17 | Day |
recurrent acute pancreatitis
chronic pancreatitis
follow-up for 2 years
none
abdominal pain
Completed
2008 | Year | 03 | Month | 01 | Day |
2008 | Year | 04 | Month | 21 | Day |
2008 | Year | 05 | Month | 01 | Day |
2020 | Year | 05 | Month | 01 | Day |
2008 | Year | 02 | Month | 26 | Day |
2022 | Year | 11 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001267